| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B | $0.1B | $0.1B |
| Gross Profit | — | — | — | — | — | $0.1B | $0.0B | $0.0B |
| R&D Expense | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Operating Income | $0.1B | $-0.0B | $0.1B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B |
| Net Income | $0.0B | $-0.0B | $0.0B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $0.87 | $-0.46 | $0.75 | $3.35 | $2.33 | $0.37 | $0.07 | $0.13 |
| EPS (Diluted) | $0.86 | $-0.46 | $0.74 | $3.24 | $2.24 | $0.36 | $0.07 | $0.12 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.9B | $2.8B | $2.8B | $2.5B | $2.4B | $1.9B | $1.4B | $0.8B |
| Current Assets | $1.1B | $1.1B | $1.1B | $1.0B | $0.9B | $0.9B | $0.6B | $0.3B |
| Cash & Equivalents | $0.6B | $0.8B | $0.8B | $0.5B | $0.6B | $0.7B | $0.5B | $0.2B |
| Total Liabilities | $0.8B | $0.9B | $0.9B | $0.6B | $0.6B | $0.4B | $0.3B | $0.2B |
| Current Liabilities | $0.1B | $0.1B | $0.2B | $0.4B | $0.4B | $0.3B | $0.0B | $0.1B |
| Stockholders' Equity | $2.1B | $2.0B | $2.0B | $1.9B | $1.8B | $1.5B | $1.1B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.0B |
| Investing Cash Flow | $-0.3B | $-0.1B | $-0.1B | $-0.2B | $-0.2B | $-0.2B | $-0.2B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $-0.1B | $0.2B | $-0.0B | $0.0B | $0.3B | $0.5B | $0.0B |